A Safety Study of Human Cord Blood Derived, Culture Expanded Natural Killer Cell (PNK-007) Infusion With Subcutaneous Recombinant Human IL-2 (rhIL-2) in Adults With Relapsed and/or Refractory Acute Myeloid Leukemia (AML)
Clinical trial NCT02781467 · TERMINATED
Trial details
- NCT number
- NCT02781467
- Sponsor
- Celularity Incorporated
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-11
- Primary completion
- 2017-12-07
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.